1305P Health-related quality of life (HRQoL) in a phase III study of first-line brigatinib (BRG) vs crizotinib (CRZ) in NSCLC: Updated results from ALTA-1L
| Autor: | Campelo, M.R. Garcia, Zhu, Y., Lin, H.M., Pérol, M., Jahanzeb, M., Popat, S., Zhang, P., Goodman, E., Camidge, D.R. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S844-S844 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|